158 related articles for article (PubMed ID: 32114573)
1. A Promising Innovative Treatment for ST-Elevation Myocardial Infarction: The Use of C-Reactive Protein Selective Apheresis: Case Report.
Boljevic D; Nikolic A; Rusovic S; Lakcevic J; Bojic M; Balint B
Blood Purif; 2020; 49(6):753-757. PubMed ID: 32114573
[TBL] [Abstract][Full Text] [Related]
2. Selective C-Reactive Protein-Apheresis in Patients.
Ries W; Heigl F; Garlichs C; Sheriff A; Torzewski J
Ther Apher Dial; 2019 Dec; 23(6):570-574. PubMed ID: 30924312
[TBL] [Abstract][Full Text] [Related]
3. PentraSorb C-Reactive Protein: Characterization of the Selective C-Reactive Protein Adsorber Resin.
Mattecka S; Brunner P; Hähnel B; Kunze R; Vogt B; Sheriff A
Ther Apher Dial; 2019 Oct; 23(5):474-481. PubMed ID: 30697961
[TBL] [Abstract][Full Text] [Related]
4. Early Selective C-Reactive Protein Apheresis in a Patient with Acute ST Segment Elevation Myocardial Reinfarction.
Milosevic M; Balint B; Boskovic S; Bojic M; Nikolic A; Otasevic P
Blood Purif; 2021; 50(3):399-401. PubMed ID: 32998146
[TBL] [Abstract][Full Text] [Related]
5. C-Reactive Protein Apheresis as Anti-inflammatory Therapy in Acute Myocardial Infarction: Results of the CAMI-1 Study.
Ries W; Torzewski J; Heigl F; Pfluecke C; Kelle S; Darius H; Ince H; Mitzner S; Nordbeck P; Butter C; Skarabis H; Sheriff A; Garlichs CD
Front Cardiovasc Med; 2021; 8():591714. PubMed ID: 33778017
[No Abstract] [Full Text] [Related]
6. "First in Man": Case Report of Selective C-Reactive Protein Apheresis in a Patient with Acute ST Segment Elevation Myocardial Infarction.
Ries W; Sheriff A; Heigl F; Zimmermann O; Garlichs CD; Torzewski J
Case Rep Cardiol; 2018; 2018():4767105. PubMed ID: 30533227
[TBL] [Abstract][Full Text] [Related]
7. Selective apheresis of C-reactive protein: a new therapeutic option in myocardial infarction?
Sheriff A; Schindler R; Vogt B; Abdel-Aty H; Unger JK; Bock C; Gebauer F; Slagman A; Jerichow T; Mans D; Yapici G; Janelt G; Schröder M; Kunze R; Möckel M
J Clin Apher; 2015 Feb; 30(1):15-21. PubMed ID: 25044559
[TBL] [Abstract][Full Text] [Related]
8. Sustainability of C-Reactive Protein Apheresis in Acute Myocardial Infarction-Results from a Supplementary Data Analysis of the Exploratory C-Reactive Protein in Acute Myocardial Infarction-1 Study.
Skarabis H; Torzewski J; Ries W; Heigl F; Garlichs CD; Kunze R; Sheriff A
J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362673
[TBL] [Abstract][Full Text] [Related]
9. Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction.
Reindl M; Reinstadler SJ; Feistritzer HJ; Klug G; Tiller C; Mair J; Mayr A; Jaschke W; Metzler B
Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):640-649. PubMed ID: 27440935
[TBL] [Abstract][Full Text] [Related]
10. Case Report: C-Reactive Protein Apheresis in a Patient With COVID-19 and Fulminant CRP Increase.
Ringel J; Ramlow A; Bock C; Sheriff A
Front Immunol; 2021; 12():708101. PubMed ID: 34408751
[TBL] [Abstract][Full Text] [Related]
11. First-in-Man: Case Report of Selective C-Reactive Protein Apheresis in a Patient with SARS-CoV-2 Infection.
Torzewski J; Heigl F; Zimmermann O; Wagner F; Schumann C; Hettich R; Bock C; Kayser S; Sheriff A
Am J Case Rep; 2020 Jul; 21():e925020. PubMed ID: 32661220
[TBL] [Abstract][Full Text] [Related]
12. High-sensitivity C-reactive protein and long term reperfusion success of primary percutaneous intervention in ST-elevation myocardial infarction.
Groot HE; Karper JC; Lipsic E; van Veldhuisen DJ; van der Horst ICC; van der Harst P
Int J Cardiol; 2017 Dec; 248():51-56. PubMed ID: 28826799
[TBL] [Abstract][Full Text] [Related]
13. Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage : Kinetic profile, relationship to interleukin 6 and infarct size.
Butt N; Bache-Mathiesen LK; Ushakova A; Nordrehaug JE; Jensen SE; Munk PS; Danchin N; Dubois-Rande JL; Hansen HS; Paganelli F; Corvoisier PL; Firat H; Erlinge D; Atar D; Larsen AI
Eur Heart J Acute Cardiovasc Care; 2020 Jun; 9(4):302-312. PubMed ID: 32403934
[TBL] [Abstract][Full Text] [Related]
14. Non-contrast cardiac CT immediately after percutaneous coronary intervention: does it predict the risk of left ventricular remodeling in patients with ST-elevation myocardial infarction?
Khurelsukh K; Kim YH; Seon HJ; Song JH; Park SY; Moon SM; Kim SH; Sim DS; Ahn Y
Int J Cardiovasc Imaging; 2016 Jun; 32 Suppl 1():147-54. PubMed ID: 27139462
[TBL] [Abstract][Full Text] [Related]
15. COLIN trial: Value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response.
Akodad M; Lattuca B; Nagot N; Georgescu V; Buisson M; Cristol JP; Leclercq F; Macia JC; Gervasoni R; Cung TT; Cade S; Cransac F; Labour J; Dupuy AM; Roubille F
Arch Cardiovasc Dis; 2017; 110(6-7):395-402. PubMed ID: 28065445
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Infarct Transmurality From C-Reactive Protein Level and Mean Platelet Volume in Patients With ST-Elevation Myocardial Infarction: Comparison of the Predictive Values of Cardiac Enzymes.
Kim D; Choi DH; Kim BB; Choi SW; Park KH; Song H
J Clin Lab Anal; 2016 Nov; 30(6):930-940. PubMed ID: 27075615
[TBL] [Abstract][Full Text] [Related]
17. Endothelial function after ST-elevation myocardial infarction in patients with high levels of high-sensitivity CRP and Lp-PLA
Kandhai-Ragunath JJ; de Wagenaar B; Doelman C; van Es J; Jørstad HT; Peters RJG; Doggen CJM; von Birgelen C
Cardiovasc Revasc Med; 2017; 18(3):202-206. PubMed ID: 28110894
[TBL] [Abstract][Full Text] [Related]
18. Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: The REMODELING Trial.
Park Y; Tantry US; Koh JS; Ahn JH; Kang MG; Kim KH; Jang JY; Park HW; Park JR; Hwang SJ; Park KS; Kwak CH; Hwang JY; Gurbel PA; Jeong YH
Thromb Haemost; 2017 May; 117(5):911-922. PubMed ID: 28150852
[TBL] [Abstract][Full Text] [Related]
19. Association of Myocardial Injury With Serum Procalcitonin Levels in Patients With ST-Elevation Myocardial Infarction.
Reindl M; Tiller C; Holzknecht M; Lechner I; Henninger B; Mayr A; Brenner C; Klug G; Bauer A; Metzler B; Reinstadler SJ
JAMA Netw Open; 2020 Jun; 3(6):e207030. PubMed ID: 32539151
[TBL] [Abstract][Full Text] [Related]
20. High Serum Secreted Frizzled-Related Protein 5 Levels Associates with Early Improvement of Cardiac Function Following ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.
Du Y; Zhao Y; Zhu Y; Hu C; Zhang J; Ji Q; Liu W; Han H; Yang L; Zhang D; Tong S; Wang Z; Guo Y; Liu X; Zhou Y
J Atheroscler Thromb; 2019 Oct; 26(10):868-878. PubMed ID: 30773518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
